AMN Healthcare Files 8-K for Corporate Changes

Ticker: AMN · Form: 8-K · Filed: 2025-12-11T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, filing-update

Related Tickers: AMN

TL;DR

AMN Healthcare just filed an 8-K for corporate changes - keep an eye on governance/reporting shifts.

AI Summary

AMN Healthcare Services, Inc. filed an 8-K on December 11, 2025, to report amendments to its Articles of Incorporation or Bylaws, or a change in its fiscal year. The filing indicates a change in the company's corporate structure or reporting period, with its principal executive offices located at 2999 Olympus Boulevard, Suite 300, Dallas, Texas.

Why It Matters

This filing signals potential changes in AMN Healthcare's governance or financial reporting structure, which could impact how investors interpret its financial performance and corporate actions.

Risk Assessment

Risk Level: low — The filing is procedural and relates to corporate structure or reporting periods, not a direct financial event.

Key Players & Entities

FAQ

What specific amendments were made to the Articles of Incorporation or Bylaws, or what change in fiscal year was reported?

The filing indicates amendments to Articles of Incorporation or Bylaws, or a change in fiscal year, but the specific details of these changes are not provided in the excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on December 11, 2025.

What is the principal executive office address for AMN Healthcare Services, Inc.?

The principal executive offices are located at 2999 Olympus Boulevard, Suite 300, Dallas, Texas 75019.

What is the company's state of incorporation?

The company is incorporated in Delaware.

What is the filing's purpose according to the 'ITEM INFORMATION' section?

The filing is to report Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

From the Filing

0001142750-25-000058.txt : 20251211 0001142750-25-000058.hdr.sgml : 20251211 20251211165547 ACCESSION NUMBER: 0001142750-25-000058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 55 CONFORMED PERIOD OF REPORT: 20251211 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year FILED AS OF DATE: 20251211 DATE AS OF CHANGE: 20251211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMN HEALTHCARE SERVICES INC CENTRAL INDEX KEY: 0001142750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services EIN: 061500476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16753 FILM NUMBER: 251565593 BUSINESS ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 BUSINESS PHONE: 8668718519 MAIL ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 8-K 1 amn-20251211.htm 8-K amn-20251211 0001142750 false 12/31 0001142750 2025-12-11 2025-12-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ____________________ FORM 8-K _____________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 11, 2025 AMN HEALTHCARE SERVICES, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-16753 06-1500476 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2999 Olympus Boulevard , Suite 300 Dallas , Texas 75019 (Address of Principal Executive Offices) Registrant’s telephone number, including area code: ( 866 ) 871-8519 NOT APPLICABLE (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b)) ☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, par value $0.01 per share AMN NYSE ☐ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On December 11, 2025, the Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) adopted and approved amended and restated by-laws of the Company (the “By-laws”) to, among other things: • Align the By-laws with developments in Delaware law; • Revise procedural mechanics and disclosure requirements applicable to stockholder-requested special meetings; • Clarify the powers of the Board and the chair of a stockholder meeting to regulate conduct at a meeting; • Revise procedural mechanics and disclosure requirements applicable to stockholder nominations of directors and submissions of proposals regarding other business at stockholder meetings, including to clarify the scop

View on Read The Filing